Curated content that matters
Explore stories across diverse categories
Cho Won-tae, chairman of Hanjin Group, received record compensation last year even as key affiliates reported weakening earnings,
Nvidia Chief Executive Jensen Huang on March 16 (local time) praised Samsung Electronics as a key partner in
South Korea’s LG CNS, the IT and digital transformation arm of LG Group, is emerging as part of
SK Hynix, a South Korean semiconductor manufacturer and one of the world’s largest producers of memory chips used
Photo=Hyundai Motor Group’ Hyundai Motor Group’s decision not to exercise its buyback option on its former Russian manufacturing plant is fueling speculation that the South Korean automaker may be closing the chapter on Russia—at least for the foreseeable future. The group confirmed earlier this month that it would not repurchase its flagship St. Petersburg factory, a move that effectively rules
(Photo=anua) As competition intensifies in the U.S. skincare market, where product claims have become increasingly interchangeable, brands are searching for ways to differentiate beyond formulation. Anua, a South Korea–based skincare company, is taking that approach by anchoring a global campaign to a collaboration with the Netflix film K-Pop Demon Hunters, using narrative rather than novelty to frame its products. The
Photo=Next Biomedical Next Biomedical Co., a South Korean medical-device specialist, said it has received regulatory approval in Canada for its absorbable embolic microsphere used to treat musculoskeletal pain, a milestone the company says will accelerate its expansion into North America ahead of a planned U.S. launch. The company said on Jan. 29 (local time) that Health Canada granted market authorization
Samsung Bioepis said it has reached a licensing and settlement agreement with Regeneron Pharmaceuticals Inc. and Bayer AG covering its biosimilar version of Eylea, clearing the way for launches across major global markets outside the U.S. and Canada. The agreement αφορά Opfobiz, Samsung Bioepis’s biosimilar to Eylea (active ingredient: aflibercept), a leading treatment for retinal diseases. Under the deal, Samsung
Photo=Hyundai South Korean President Lee Jae-myung has delivered one of his clearest warnings yet about the country’s industrial future, arguing that resistance to humanoid robots on factory floors risks leaving the nation unprepared for an inevitable technological shift. His remarks, aimed squarely at labor opposition within the auto sector, have intensified a public clash with one of South Korea’s most
